l cegedim
Ugdafeoti
IMS Health Transaction
Conference Cali - October 20th, 2014 at 6.00pm CET
Innovation
STRATEGY
Strength
Safe Harbor
Statement
This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward- looking statements involve risk and uncertainty. Forward-looking statements represent the company's judgment regarding future events, and are based on currently available information. Consequently the company cannot guarantee their accuracy and their completeness, and actual results may differ materially from those the company anticipated due to a number of uncertainties, many of which the company is not aware of. For additional information concerning these and other important factors that may cause the company's actual results to differ materially from expectations and underlying assumptions, please refer to the reports filed by the company with the 'Autorité des Marchés Financiers'.
•'•cegedim
Definitive Purchase Agreement Executed C
Selling Price
€385m
Use of Proceeds
Repay Debt
Closing
Early Q2 2015
Positive opinion from ali countries where the consultations were required
Confirmation that the Article 236-6 of its Generai Regulations did not apply
Positive reaction from the market
Positive feedback from clients
IMS Health's investment capacity and strategie plans for the activities
(1) On a cash free debt free basis, subjecl to certa/n ad}uslmenls based on t!Je Group's nel debt allhe dale of complenon. changes in nel worl
and 2014 CRM and strategiedata division revenue
This document should not be distributed without Cegedim authorization- Copyright 2014 3
•'•cegedim
June 24, 2014 July l October 2014
Reception of the offer
Pubiic
Announcement
Consultation
October 2014 l 01 2015
Regulatory Process
Early 02 2015
Closing
(1) On a cash free debt free basis, subject to certa/n adjustments based an the Group's net debt at the date of comp!etion, changes in net working capita/ and 2014 CRM and strategie data division revenue
This document should not be distributed without Cegedim authorization- Copyright 2014 4
••cegedim
•
•
IMS Health Transaction: FAQ C
How will we use the net proceeds?
To reduce debt by:
• repayment of the 2015 Band maturing in July 2015
• total or partial redemption of the 2020 Band
depending of market conditions
What will happen to the New Group?
Cegedim wili:
• remain listed
• have a significant level of margin
• remain committed to invest in market with high potential
• look far targeted acquisitions in its business areas
This document should not be distributed without Cegedim authorization- Copyright 2014 5
•c•egedim
New Cegedim: Breakdown by Clients C
FOR HEALTHCARE PROFESSIONALS
32%
of 2013 pro-forma revenue
CHS
• Cegedim Activ
• Cetip
• iGestion
• Midiway
•
• Kadrige
• GERS
*
• Cegedim SRH
• Cegedim Outsourcing
• Cegedim e-business
• Cegelease
This document should not be distributed without Cegedim authorization- Copyright 2014
cegedim
6
•l•?:: cegedim
a For 2014,the Group is reconfirming its target
At least stable revenue and operating margin from recurring operations. For H2 2014 the Group expects:
• A slight slowdown at the CRM and Stategic Data division
• A slight increase in activity at the other divisions
• Owing to a less demanding comparison level for UK Doctors Software in H2-2014
• Owing to a restored order book at software for French Pharmacists
>Point to a positive revenue developments in H2-2014
• The Group will be led to recognize an accounting loss of approximately €180 million, with no impact on the Group's cash at the end of 2014.
These projections were pub!icy disc!osed an October 20ih, 2014. The fact dJat Cegedim inc!udes these projecffons in dJis presentation shou!d not be taken to mean dJat dJese projections continue to be our projecffons as of any subsequent date.
This document should noi be distributed without Cegedim authorization- Copyright 2014 7
•'•cegedim
October 28th
03-2014 RevenueDecember 16th
5th lnvestor Day
Avaiabe
This Document includes the Financial Statements and Management
Report for the second quarter and the first half of 2014
This document should not be distributed without Cegedim authorization- Copyright 2014 8
••cegedim
Our IR App is now available C
l.cegedlm e RE Sulls O
c-• .....
cegedim "'e
2.6...9.5.....(.13.3.'!1,111-011201•17::15
trA HM 2t.tl U» f.J..tll
· ®
'J ..........,....................
AVA -•••
http://www.cegedim.com/CegedimiR
The Cegedim IR app far Android, iPhone* and iPad* lets you follow Cegedim financial news and receive customized push notifications, and gives access to ali the information an investor or journalist might want.
* iPhone is the exclusive property of Appie !ne., registered in the U.S. and other countries.
This document should not be distributedwithout Cegedim authorization- Copyright 2014 9
We welcome your questions and comments
Jan Eryk UMIASTOWSKI
Chief Investment Officer
Head of Investor Relations
Janeryk.umiastowski@cegedim.com
www.cegedim.com/finance
TEL: +33 (0) 1 49 09 33 36
distributed by |